Navigation Links
Circle Biologics® Introduces Innovation in Medical Devices
Date:7/26/2010

MINNEAPOLIS, July 26 /PRNewswire/ -- Circle Biologics®, Inc. has announced a technological break-through in regenerative medicine – its Autologous Platelet Concentrator Platform (APC™).  This innovative single device platform is the first of its kind to incorporate both autologous (patient derived) cell concentration and protein concentration in one point-of-care device.

The APC patented design (which has earned the US Food and Drug Administration's 510(k) marketing approval from its Office of Cellular, Tissue and Gene Therapies for creation of Platelet Rich Plasma and concentrated Platelet Poor Plasma) is a two-chamber, closed system that allows the user to perform two processing steps without the risk of contamination or waste, typically associated with transferring fluids between devices.

According to Matthew Kyle, president of Circle Biologics, this device will bring significant benefits to the surgical and healing processes associated with Cardiosurgery, Orthopedics, Cosmetic Surgery and Dental care.

"While this is not the first platelet-rich plasma device on the market, it is the first to incorporate both patient derived cell and protein concentration in one," says Kyle.  "It's a technological advancement in treating the entire medical procedure, giving improved solutions for patients and providers."

With its unique insights to medical care, Circle Biologics is standardizing the process of patient derived, patient point of care bio-fluid and cellular preparation across several therapies (i.e., platelet-rich plasma, stem cell, and tissue enrichment/generation). Additionally, the company has developed solutions that address the entire procedure—from procurement to processing to delivery or implantation—with a streamlined combination of devices that spare cells, reduce outside exposure, and protect the user and recipient.

About Circle Biologics

Circle Biologics, Inc.  develops, manufactures and markets patented devices for the regenerative medicine industry. The company is integrating cutting-edge biologic treatments with proven surgical techniques, resulting in seamless point-of-care solutions.  Circle Biologics focuses on bringing innovative solutions to market that address the entire medical procedure and improve biological fluid access, processing, handling and delivery.  The privately-held company is headquartered in Minneapolis, Minnesota.  www.circlebiologics.com


'/>"/>
SOURCE Circle Biologics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Circle Medical Devices, Texcel Medical Merge to Form CIRTEC Medical Systems
2. DrChrono.com iPad EMR Introduces Macros, Customizable SOAP Notes
3. PEAK Surgical Introduces PEAK PlasmaBlade(R) 3.0S
4. Invision Sally Jobe Introduces New Breast Cancer Screening Technology to Denver
5. Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
6. Ethicon Endo-Surgery Introduces HARMONIC ACE® 45 cm Curved Shears at ASMBS
7. Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
8. Nonin Medical Introduces Latest Generation of Veterinary Handheld Pulse Oximeter for Global Distribution
9. PLUS Diagnostics Introduces Industrys First System to Eliminate Misidentification of Bone Marrow Samples
10. Upsher-Smith Introduces New Formulation of PreNexa® Prenatal Vitamins
11. Maxam Nutraceutics Introduces PCA-Rx as a Natural Chelation Alternative for Autism Spectrum Disorder Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... SHAWNEE, Kan. , April 27, 2016 /PRNewswire/ ... Martabano , a senior from the University of ... winner of the Bayer Excellence in Communication Award ... veterinary schools, which were awarded a total of ... Over the last four years, Bayer has provided ...
(Date:4/27/2016)... , April 27, 2016 ... over USD 2.14 billion by 2022, according to ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ... advancement affecting the efficiency and accuracy delivered by ... persistent demand for novel urinalysis instruments and consumables. ...
(Date:4/26/2016)... CHICAGO , April 26, 2016 Hill-Rom Holdings, ... to a management presentation at the Deutsche Bank 41 st ... at 2:50 p.m. EDT. You are invited to ... http://ir.hill-rom.com/events.cfm or access it directly at http://edge.media-server.com/m/p/mr4uxgas ... one hour after conclusion of the live event and accessible ...
Breaking Medicine Technology:
(Date:4/28/2016)... (PRWEB) , ... April 28, ... ... Standards Consortium (CDISC) announces today the open availability of a new CDISC ... and catalogs for registering clinical trials. This innovative standard will make it ...
(Date:4/28/2016)... ... April 28, 2016 , ... In many parts of the world, contamination ... mortality. This is particularly true in underdeveloped parts of Africa where clean sources of ... England’s campus in Tangier, Morocco, will examine this global health issue and consider how ...
(Date:4/28/2016)... ... 28, 2016 , ... One way to ignore solid evidence is to dismiss ... we toss the baby out with the bathwater when we ignore all studies because ... studies and otherwise making better use of education policy research. , “When readers heed ...
(Date:4/28/2016)... ... 28, 2016 , ... Point Source Audio® (PSA) , ... announced today that the US Patent Office has approved its patent submission that ... innovative design creates a lightweight and modular audio headset that has been said ...
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... ... containerization, today announced it will demonstrate its leading secure mobility workstation suite, SentinelSecure™, ... , Held at Hilton Union Square, this will be MobileIron’s 6th Mobile First ...
Breaking Medicine News(10 mins):